Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA

Bavachinin protects the liver in NAFLD by promoting regeneration via targeting PCNA

Introduction: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease all over the world, and no drug is approved for the treatment of NAFLD. Bavachinin (BVC) is proven to possess liver-protecting effect against NAFLD, but its mechanism is still blurry. Objectives: With the use of...

Full description

Bibliographic Details
Main Authors: Xi Dong, Shan Lu, Yu Tian, Han Ma, Yang Wang, Xuelian Zhang, Guibo Sun, Yun Luo, Xiaobo Sun
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of Advanced Research
Subjects:
Bavachinin
CC-ABPP
NAFLD
Liver regeneration
PCNA
Online Access:http://www.sciencedirect.com/science/article/pii/S2090123223000590

Similar Items

Similar Items